CTAP 001

Drug Profile

CTAP 001

Alternative Names: CTAP001 Capsules

Latest Information Update: 21 Apr 2014

Price : $50

At a glance

  • Originator Cytochroma
  • Class Vitamins
  • Mechanism of Action Calcitriol receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Vitamin D deficiency

Most Recent Events

  • 04 Mar 2013 Cytochroma has been acquired by OPKO Health
  • 28 Oct 2008 Discontinued - Phase-III for Vitamin D deficiency in Canada (PO)
  • 22 Nov 2007 Phase-III clinical trials in Vitamin D deficiency in Canada (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top